A drug originally designed for chemotherapy may reduce allergic responses for a variety of allergens, according to a study published in the Journal of Allergy and Clinical Immunology.
Patients with an advanced form of kidney cancer have similar quality of life outcomes on a therapy called cabozantinib, compared to those on a standard treatment.
Scientists throughout Feinberg are deeply invested in identifying health disparities — those differences in health outcomes between populations — as well as exploring novel interventions.
Northwestern Medicine scientists have discovered why Huntington’s disease is so toxic to cancer cells and have harnessed it for a novel approach to treat cancer.
Antibodies that reverse immune system suppression may be able to be used to treat a rare type of melanoma, according to a Northwestern Medicine study published in the journal Nature.
Northwestern Medicine scientists have demonstrated that tiny vesicles called exosomes released from non-metastatic melanoma cells trigger an immune response that prevents cancer from spreading throughout the body.
A team of scientists has demonstrated a novel approach to delivering cancer drugs directly to tumor cells, through gold nanoparticles that can be remotely triggered to release therapies.
A combination of three therapies was found to provide the greatest benefit to patients with metastatic breast cancer classified as HER2- and hormone receptor-positive, who aren’t candidates for chemotherapy, according to a Northwestern Medicine clinical trial.
A new Northwestern Medicine study detailed a technique that could help scientists find the cause of cancer or autism-spectrum disease stemming from faulty protein disposal.
A device attached to a patient’s scalp that delivers a continuous dose of low-intensity electric fields improves survival and slows the growth of a deadly brain tumor, according to a new trial.